| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |